Source-grounded facts extracted from COLGATE PALMOLIVE CO's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
COLGATE PALMOLIVE CO shareholders rejected Stockholder proposal: Independent Board Chairman at the 2026-05-08 meeting.
“5. A stockholder proposal entitled “Independent Board Chairman” was not approved. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 182,439,869 452,415,385 2,798,155 63,952,735”
COLGATE PALMOLIVE CO shareholders rejected Stockholder proposal: Remove DEI from Board Candidate Considerations at the 2026-05-08 meeting.
“4. A stockholder proposal entitled “Remove DEI from Board Candidate Considerations” was not approved. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 14,002,273 618,251,142 5,399,994 63,952,735”
COLGATE PALMOLIVE CO shareholders approved Non-binding advisory vote on the Company's executive compensation at the 2026-05-08 meeting.
“3. A non-binding advisory vote on the Company’s executive compensation was approved. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 591,185,556 43,039,011 3,428,842 63,952,735”
COLGATE PALMOLIVE CO shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for year ending December 31, 2026 at the 2026-05-08 meeting.
“2. The selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 647,385,500 53,015,911 1,204,733 0”
COLGATE PALMOLIVE CO shareholders approved Election of Directors at the 2026-05-08 meeting.
“1. John P. Bilbrey, Christopher S. Boerner, John T. Cahill, Lisa M. Edwards, C. Martin Harris, Martina Hund-Mejean, Kimberly A. Nelson, Brian O. Newman, Lorrie M. Norrington and Noel Wallace were elected directors of the Company. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes John P. Bilbrey 609,562,498 26,889,533 1,201,378 63,952,735 Christopher S. Boerner 630,748,353 5,728,013 1,177,043 63,952,735 John T. Cahill 580,860,042 55,593,274 1,200,093 63,952,735 Lisa M. Edwards 619,731,808 16,863,927 1,057,674 63,952,735 C. Martin Harris 590,342,138 45,972,687 1,338,584 63,952,735 Martina Hund-Mejean 619,941,994 16,738,461 972,954 63,952,735 Kimberly A. Nelson 625,713,274 10,465,248 1,474,887 63,952,735 Brian O. Newman 619,994,950 16,558,323 1,100,136 63,952,735 Lorrie M. Norrington 616,023,271 20,101,409 1,528,729 63,952,735 Noel Wallace 594,674,983 39,258,389 3,720,037 63,952,735”
COLGATE PALMOLIVE CO reported financial results for the quarter ended March 31, 2026.
“On May 1, 2026, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended March 31, 2026. This press release is attached as Exhibit 99 and is incorporated herein by reference.”
COLGATE PALMOLIVE CO announced a restructuring with charges of Total pre-tax charges estimated between $350 million and $550 million, increased from $200-$300 million, comprising employee-related costs (70%-80%) and asset-r affecting North America (5%-10%), Latin America (15%-20%), Europe, Middle East & Africa (25%-30%), Asia Pacific (10%-15%), Hill's Pet Nutrition (10%-15%), and Corporate (20%-25%) (Employee-related costs, including severance and other termination benefits (70% to 80% of total charges)).
“Building on the successful implementation of the Strategic Growth and Productivity Program to date, on April 30, 2026, the Company’s Board approved an expansion of the program to continue to align the Company’s operations to drive future growth and support the Company’s 2030 strategy. The Strategic Growth and Productivity Program is now estimated to result in cumulative pre-tax charges, once all initiatives are approved and implemented, totaling between $350 million and $550 million, increased from $200 million to $300 million. These pretax charges are currently estimated to be comprised of the following: employee-related costs, including severance and other termination benefits (70% to 80%) and asset-related costs and other charges (20% to 30%), which include accelerated depreciation, asset write-offs, contract termination and other exit costs. It is estimated that approximately 80% to 90% of the charges will result in cash expenditures and substantially all charges resulting from the”
COLGATE PALMOLIVE CO announced a restructuring with charges of $200 and $300 million affecting North America, Latin America, Europe, Asia Pacific, Africa/Eurasia, Hill's Pet Nutrition, Corporate.
“the Company’s Board of Directors approved a new three-year productivity program to drive future growth and support the Company’s 2030 strategy (the “Strategic Growth and Productivity Program”). The program includes initiatives to better align the Company’s organizational structure to support its strategic initiatives, optimize the Company’s global supply chain to drive agility and efficiencies and simplify and streamline its organizational structure to reduce overhead costs. The Strategic Growth and Productivity Program is estimated to result in cumulative pre-tax charges, once all initiatives are approved and implemented, totaling between $200 and $300 million”
COLGATE PALMOLIVE CO announced a restructuring with charges of between $200 and $300 million affecting Corporate segment.
“The Productivity Program is projected to result in cumulative pre-tax charges, once all initiatives are approved and implemented, totaling between $200 and $300 million over the course of the three-year program.”
John Hazlin changed role as Chief Growth Officer at COLGATE PALMOLIVE CO.
“and John Hazlin to the position of Chief Growth Officer”
Panagiotis Tsourapas changed role as Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development at COLGATE PALMOLIVE CO.
“The Board also approved the promotion of Panagiotis Tsourapas to the position of Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development”
Prabha Parameswaran departed as Vice Chair at COLGATE PALMOLIVE CO.
“has communicated to the Company her intention to retire from the Company on October 1, 2025.”
Prabha Parameswaran was elected as Vice Chair at COLGATE PALMOLIVE CO.
“the Board has elected Ms. Parameswaran Vice Chair of the Company, effective June 16, 2025.”
Shane Grant was appointed as Chief Operating Officer, Americas at COLGATE PALMOLIVE CO.
“the Company announced that its Board of Directors (the “Board”) had elected Shane Grant as the Company’s Chief Operating Officer, Americas, reporting to Chairman, President and Chief Executive Officer, Noel R. Wallace, effective June 16, 2025.”
COLGATE PALMOLIVE CO shareholders rejected Stockholder proposal on independent Board Chairman at the 2024-05-10 meeting.
“4. A stockholder proposal on independent Board Chairman was not approved.”
COLGATE PALMOLIVE CO shareholders approved Non-binding advisory vote on executive compensation at the 2024-05-10 meeting.
“3. A non-binding advisory vote on the Company’s executive compensation was approved.”
COLGATE PALMOLIVE CO shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2024-05-10 meeting.
“2. The selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024 was ratified.”
COLGATE PALMOLIVE CO shareholders approved Election of Directors at the 2024-05-10 meeting.
“1. John P. Bilbrey, John T. Cahill, Steve Cahillane, Lisa M. Edwards, C. Martin Harris, Martina Hund-Mejean, Kimberly A. Nelson, Brian Newman, Lorrie M. Norrington, and Noel R. Wallace were elected directors of the Company.”
COLGATE PALMOLIVE CO reported the quarter ended March 31, 2024 results: revenue $5,065, EPS $0.83.
“• The Company updated its financial guidance for full year 2024 First Quarter Total Company Results (GAAP) ($ in millions except per share amounts) 2024 2023 Change Net Sales $5,065 $4,770 +6.2 % EPS (diluted) $0.83 $0.45 +84 % First Quarter Total Company Results (Base Business - Non-GAAP)* 2024 2023 Change Organic Sales Growth +9.8 % Base Business EPS”
Stephen I. Sadove departed as Director at COLGATE PALMOLIVE CO.
“Stephen I. Sadove, 72, will retire as a director at the end of his current term and will not stand for reelection to the Board at the Annual Meeting of Stockholders to be held on May 10, 2024.”
Brian Newman was elected as Director at COLGATE PALMOLIVE CO.
“elected Brian Newman, Executive Vice President and Chief Financial Officer of United Parcel Service, Inc. (“UPS”), to the Colgate Board, effective March 15, 2024.”
COLGATE PALMOLIVE CO reported the quarter and year ended December 31, 2023 results: revenue $19,457, EPS $2.77.
“in fourth quarter 2022 Base Business EPS* increased 9% to $3.23 Full Year Total Company Results (GAAP) ($ in millions except per share amounts) 2023 2022 Change Net Sales $19,457 $17,967 +8.5% EPS (diluted) $2.77 $2.13 +30% Full Year Total Company Results (Base Business - Non-GAAP)* ($ in millions except per share amounts) 2023 2022 Change Organic Sales”
COLGATE PALMOLIVE CO updated its the quarter ended September 30, 2023 guidance (raised).
“On October 27, 2023, Colgate-Palmolive Company (the "Company") issued a press release announcing its earnings for the quarter ended September 30, 2023.”
Michael B. Polk resigned as Director at COLGATE PALMOLIVE CO.
“On August 18, 2023, Michael B. Polk resigned from Colgate-Palmolive Company’s Board of Directors for personal reasons.”
COLGATE PALMOLIVE CO shareholders rejected Stockholder proposal on executives to retain significant stock at the 2023-05-12 meeting.
“A stockholder proposal on executives to retain significant stock was not approved.”
COLGATE PALMOLIVE CO shareholders rejected Stockholder proposal on independent Board Chairman at the 2023-05-12 meeting.
“A stockholder proposal on independent Board Chairman was not approved.”
COLGATE PALMOLIVE CO shareholders approved Non-binding advisory vote on frequency of future advisory votes on executive compensation at the 2023-05-12 meeting.
“A non-binding advisory vote on the frequency of future non-binding advisory votes on the Company’s executive compensation was held and the frequency that received the most votes was one year.”
COLGATE PALMOLIVE CO shareholders approved Non-binding advisory vote on executive compensation at the 2023-05-12 meeting.
“A non-binding advisory vote on the Company’s executive compensation was approved.”
COLGATE PALMOLIVE CO shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2023-05-12 meeting.
“The selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 was ratified.”
COLGATE PALMOLIVE CO shareholders approved Election of Directors at the 2023-05-12 meeting.
“John P. Bilbrey, John T. Cahill, Steve Cahillane, Lisa M. Edwards, C. Martin Harris, Martina Hund-Mejean, Kimberly A. Nelson, Lorrie M. Norrington, Michael B. Polk, Stephen I. Sadove, and Noel R. Wallace were elected directors of the Company.”
COLGATE PALMOLIVE CO reported the quarter ended March 31, 2023 results: revenue $4,770, EPS $0.45.
“date The Company updated its financial guidance for full year 2023 First Quarter Total Company Results (GAAP) ($ in millions except per share amounts) 2023 2022 Change Net Sales $4,770 $4,399 +8.5% EPS (diluted) $0.45 $0.66 -32% First Quarter Total Company Results (Base Business - Non-GAAP)* 2023 2022 Change Organic Sales Growth +10.0% Base Business EPS”
Steven Cahillane was elected as Director at COLGATE PALMOLIVE CO.
“On January 30, 2023, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate”) elected Steven Cahillane, Chairman of the Board, President and Chief Executive Officer of Kellogg Company (“Kellogg”), to the Colgate Board, effective February 1, 2023.”
COLGATE PALMOLIVE CO reported financial results for the quarter and year ended December 31, 2022.
“On January 27, 2023, Colgate-Palmolive Company (the "Company") issued a press release announcing its earnings for the quarter and year ended December 31, 2022.”
COLGATE PALMOLIVE CO: Amended By-laws to update stockholder proposal procedures and forum selection clause (effective 2023-01-12).
“On January 12, 2023, the Board of Directors of Colgate-Palmolive Company (the “Company”) approved amendments to the Company’s Amended and Restated By-laws (“By-laws”), effective as of the same date.”
Philip G. Shotts changed role as Senior Vice President, Finance at COLGATE PALMOLIVE CO.
“Philip G. Shotts, who has served as the Company's Controller since June 2018, will continue as Senior Vice President, Finance, also effective June 30, 2022.”
Gregory Malcolm was elected as Vice President and Controller at COLGATE PALMOLIVE CO.
“elected Gregory Malcolm Vice President and Controller of the Company, effective June 30, 2022.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.